Comprehensive Characterization of Immune Response Induced by Adjuvanted Glycoprotein E (gE)-Based Recombinant VAccine Zoster in Vulnerable Population Receiving ImmunOmodulaNt Therapies
N/A
Varicella-zoster virus (VZV) is one of the eight herpesviruses that infect ...
Status
Recruiting
Location
Fondazione IRCCS Policlinico San Matteo di Pavia
Start Date
2026-02-24
Trial ID
NCT07534007
Personalized Vaccine for Cancer Immunotherapy
PHASE1
Due to their genetic instability, breast tumors that do not express recepto...
Status
Completed
Location
Facultad de Medicina - Universidad Nacional de Colombia
PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia
PHASE2
This is a Phase II, single institution open-label, non-randomized monothera...